Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Gadue, Paul  [Clear All Filters]
Journal Article
Mills JA, Wang K, Paluru P, Ying L, Lu L, Galvão AM, Xu D, Yao Y, Sullivan SK, Sullivan LM, et al. Clonal genetic and hematopoietic heterogeneity among human induced pluripotent stem cell lines. Blood. 2013.
Liao C-M, Mukherjee S, Tiyaboonchai A, Maguire JAnn, Cardenas-Diaz FL, French DL, Gadue P. GATA6 suppression enhances lung specification from human pluripotent stem cells. J Clin Invest. 2018.
Leavens KF, Liao C-M, Gagne AL, Kishore S, Cardenas-Diaz FL, French DL, Gadue P. Generation of a double insulin and somatostatin reporter line, SCSe001-A-3, for the advancement of stem cell-derived pancreatic islets. Stem Cell Res. 2020;50:102112.
Gagne AL, Maguire JAnn, Gandre-Babbe S, Chou ST, Tasian SK, Loh ML, Weiss MJ, Gadue P, French DL. Generation of a human Juvenile myelomonocytic leukemia iPSC line, CHOPi001-A, with a mutation in CBL. Stem Cell Res. 2018;31:157-160.
Wilken MB, Maguire JAnn, Dungan LV, Gagne A, Osorio-Quintero C, Waxman EA, Chou ST, Gadue P, French DL, Thom CS. Generation of a human Tropomyosin 1 knockout iPSC line. Stem Cell Res. 2023;71:103161.
Hashmi SK, Schneider S, Gagne AL, Maguire JAnn, Anderson S, Gadue P, Heuckeroth RO, French DL. Generation of CHOPe003-A ESC line to study an ACTG2 variant affecting smooth muscle development and function. Stem Cell Res. 2023;71:103186.
Cardenas-Diaz FL, Maguire JAnn, Gadue P, French DL. Generation of Defined Genomic Modifications Using CRISPR-CAS9 in Human Pluripotent Stem Cells. J Vis Exp. 2019;(151).
Mukherjee S, Gagne AL, Maguire JAnn, Jobaliya CD, Mills JA, Gadue P, French DL. Generation of human control iPSC line CHOPi004-A from juvenile foreskin fibroblast cells. Stem Cell Res. 2020;49:102084.
Maguire JAnn, Gagne AL, Gonzalez-Alegre P, Davidson BL, Shakkottai V, Gadue P, French DL. Generation of Spinocerebellar Ataxia Type 2 induced pluripotent stem cell lines, CHOPi002-A and CHOPi003-A, from patients with abnormal CAG repeats in the coding region of the ATXN2 gene. Stem Cell Res. 2018;34:101361.
Pavani G, Klein JG, French DL, Gadue P. Genome Engineering Human ESCs or iPSCs with Cytosine and Adenine Base Editors. Methods Mol Biol. 2022.
Maguire JAnn, Gadue P, French DL. Highly Efficient CRISPR/Cas9-Mediated Genome Editing in Human Pluripotent Stem Cells. Curr Protoc. 2022;2(11):e590.
Feng S, Wu J, Qiu W-L, Yang L, Deng X, Zhou Y, Chen Y, Li X, Yu L, Li H, et al. Large-scale Generation of Functional and Transplantable Hepatocytes and Cholangiocytes from Human Endoderm Stem Cells. Cell Rep. 2020;33(10):108455.
Mukherjee S, French DL, Gadue P. Loss of TBX3 enhances pancreatic progenitor generation from human pluripotent stem cells. Stem Cell Reports. 2021.
Kamat V, Paluru P, Myint M, French DL, Gadue P, Diamond SL. MicroRNA screen of human embryonic stem cell differentiation reveals miR-105 as an enhancer of megakaryopoiesis from adult CD34+ cells. Stem Cells. 2014.
Cardenas-Diaz FL, Osorio-Quintero C, Diaz-Miranda MA, Kishore S, Leavens K, Jobaliya C, Stanescu D, Ortiz-Gonzalez X, Yoon C, Chen CS, et al. Modeling Monogenic Diabetes using Human ESCs Reveals Developmental and Metabolic Deficiencies Caused by Mutations in HNF1A. Cell Stem Cell. 2019;25(2):273-289.e5.
Pavani G, Klein JG, Nations CC, Sussman JH, Tan K, An HHyung, Abdulmalik O, Thom CS, Gearhart PA, Willett CMarie, et al. Modeling primitive and definitive erythropoiesis with induced pluripotent stem cells. Blood Adv. 2024.
Cheng X, Barakat R, Pavani G, Usha MKhatun, Calderon R, Snella E, Gorden A, Zhang Y, Gadue P, French DL, et al. Nod1-dependent NF-kB activation initiates hematopoietic stem cell specification in response to small Rho GTPases. Nat Commun. 2023;14(1):7668.
Byrska-Bishop M, VanDorn D, Campbell AE, Betensky M, Arca PR, Yao Y, Gadue P, Costa FF, Nemiroff RL, Blobel GA, et al. Pluripotent stem cells reveal erythroid-specific activities of the GATA1 N-terminus. J Clin Invest. 2015.
Elagib KE, Brock A, Clementelli CM, Mosoyan G, Delehanty LL, Sahu RK, Pacheco-Benichou A, Fruit C, Besson T, Morris SW, et al. Relieving Dyrk1a repression of MKL1 confers an adult-like phenotype to human infantile megakaryocytes. J Clin Invest. 2022.
Garçon L, Ge J, Manjunath SH, Mills JA, Apicella M, Parikh S, Sullivan LM, Podsakoff GM, Gadue P, French DL, et al. Ribosomal and hematopoietic defects in induced pluripotent stem cells derived from Diamond Blackfan anemia patients. Blood. 2013.
Borst S, Nations CC, Klein JG, Pavani G, Maguire JAnn, Camire RM, Drazer MW, Godley LA, French DL, Poncz M, et al. Study of inherited thrombocytopenia resulting from mutations in ETV6 or RUNX1 using a human pluripotent stem cell model. Stem Cell Reports. 2021.
Sit YTing, Takasaki K, An HHyung, Xiao Y, Hurtz C, Gearhart P, Zhang Z, Gadue P, French D, Chou ST. Synergistic roles of DYRK1A and GATA1 in trisomy 21 megakaryopoiesis. JCI Insight. 2023.
Wilken MB, Fonar G, Nations C, Pavani G, Tsao V, Garifallou J, Tober J, Bennett L, Maguire JAnn, Gagne A, et al. Tropomyosin 1 deficiency facilitates cell state transitions to enhance hemogenic endothelial cell specification during hematopoiesis. bioRxiv. 2023.
An HHyung, Gagne AL, Maguire JAnn, Pavani G, Abdulmalik O, Gadue P, French DL, Westhoff CMarie, Chou ST. The use of pluripotent stem cells to generate diagnostic tools for transfusion medicine. Blood. 2022.